Edition:
United States

ICAD Inc (ICAD.OQ)

ICAD.OQ on NASDAQ Stock Exchange Capital Market

3.32USD
12:42pm EDT
Change (% chg)

$0.06 (+1.84%)
Prev Close
$3.26
Open
$3.25
Day's High
$3.32
Day's Low
$3.25
Volume
1,084
Avg. Vol
5,848
52-wk High
$4.89
52-wk Low
$2.93

Chart for

About

iCAD, Inc. is a provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The Company provides image analysis and clinical decision support solutions for mammography, Magnetic Resonance Imaging and Computed Tomography imaging. It operates in two segments:... (more)

Overall

Beta: 1.29
Market Cap(Mil.): $54.32
Shares Outstanding(Mil.): 16.66
Dividend: --
Yield (%): --

Financials

  ICAD.OQ Industry Sector
P/E (TTM): 27.24 21.45 11.54
EPS (TTM): 0.12 -- --
ROI: 9.31 6.70 18.35
ROE: 10.93 9.84 19.73

BRIEF-iCad Reports Q1 GAAP Loss Per Share $0.20

* Q1 REVENUE FELL 7 PERCENT TO $6.3 MILLION Source text for Eikon: Further company coverage:

May 14 2018

BRIEF-Icad Q4 Gaap Loss Per Share $0.26

* ICAD REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS

Mar 22 2018

BRIEF-iCAD Expects To Reduce About 18 Pct Of Workforce Across Skin Subscription Business

* ICAD INC SAYS CO EXPECTS TO REDUCE HEADCOUNT ACROSS SKIN SUBSCRIPTION BUSINESS BY ABOUT 21 EMPLOYEES OR 18% OF THE WORKFORCE- SEC FILING

Jan 05 2018

Earnings vs. Estimates